Eva Orviz

693 total citations
17 papers, 112 citations indexed

About

Eva Orviz is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Eva Orviz has authored 17 papers receiving a total of 112 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 5 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Eva Orviz's work include Reproductive tract infections research (3 papers), Herpesvirus Infections and Treatments (3 papers) and HIV/AIDS Research and Interventions (3 papers). Eva Orviz is often cited by papers focused on Reproductive tract infections research (3 papers), Herpesvirus Infections and Treatments (3 papers) and HIV/AIDS Research and Interventions (3 papers). Eva Orviz collaborates with scholars based in Spain, Ecuador and United Kingdom. Eva Orviz's co-authors include Cristina Prieto, Noemí Cabello, Jorge Vergas, Teresa Puerta, José M. Lagarón, Adrián Valls Carbó, Rocı́o Martı́n, Mar Vera, Vicente Estrada and Antonio Alcamı́ and has published in prestigious journals such as Clinical Infectious Diseases, Frontiers in Immunology and Frontiers in Microbiology.

In The Last Decade

Eva Orviz

13 papers receiving 111 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Orviz Spain 4 66 57 37 27 21 17 112
Luis Escosa Spain 7 41 0.6× 15 0.3× 27 0.7× 26 1.0× 14 0.7× 14 92
Jeffrey M. Paer United States 3 35 0.5× 44 0.8× 46 1.2× 71 2.6× 33 1.6× 9 113
Santa Elizabeth Ceballos‐Liceaga Mexico 5 33 0.5× 39 0.7× 36 1.0× 54 2.0× 7 0.3× 9 123
Francisco Homar Spain 6 26 0.4× 24 0.4× 9 0.2× 41 1.5× 19 0.9× 14 88
Lauren Poole United States 4 24 0.4× 110 1.9× 16 0.4× 91 3.4× 14 0.7× 4 157
Felanji Simukonda Malawi 3 45 0.7× 12 0.2× 13 0.4× 50 1.9× 8 0.4× 3 84
Marta Camici Italy 7 44 0.7× 22 0.4× 5 0.1× 72 2.7× 13 0.6× 20 131
Arne Jessen Germany 7 65 1.0× 132 2.3× 20 0.5× 92 3.4× 31 1.5× 10 241
Kelsie Brooks United States 7 82 1.2× 56 1.0× 14 0.4× 78 2.9× 13 0.6× 14 150
Manuela Pogliaghi Italy 7 48 0.7× 52 0.9× 6 0.2× 37 1.4× 16 0.8× 11 113

Countries citing papers authored by Eva Orviz

Since Specialization
Citations

This map shows the geographic impact of Eva Orviz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Orviz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Orviz more than expected).

Fields of papers citing papers by Eva Orviz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Orviz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Orviz. The network helps show where Eva Orviz may publish in the future.

Co-authorship network of co-authors of Eva Orviz

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Orviz. A scholar is included among the top collaborators of Eva Orviz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Orviz. Eva Orviz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Mateos, Elena, Eva Orviz, Noemí Cabello‐Clotet, et al.. (2025). Low Specific T‐Cell Immunity Against Mpox Elicited in People With HIV‐1 and PrEP Users After Subcutaneous Vaccination Compared to Natural Infection. Journal of Medical Virology. 97(7). e70498–e70498. 2 indexed citations
2.
Mazzitelli, Maria, et al.. (2024). Screening and prevention of HPV‐related anogenital cancers in women living with HIV in Europe: Results from a systematic review. HIV Medicine. 25(7). 769–793. 5 indexed citations
3.
Ayerdi, Oskar, et al.. (2024). Incidence of sexually transmitted infections and screening models among pre-exposure prophylaxis users. Enfermedades infecciosas y microbiologia clinica (English ed ). 42(10). 570–576.
4.
Vivancos, María Jesús, María Lagarde, Eva Orviz, et al.. (2024). Transition times across the HIV care continuum in Spain from 2005 to 2022: a longitudinal cohort study. The Lancet HIV. 11(7). e470–e478. 1 indexed citations
5.
Ayerdi, Oskar, et al.. (2024). Incidencia de infecciones de transmisión sexual y modelos de cribado entre usuarios de profilaxis preexposición frente al VIH. Enfermedades Infecciosas y Microbiología Clínica. 42(10). 570–576.
6.
Folch, Cinta, Clara Suñer, Yesika Díaz, et al.. (2023). Egocentric sexual network analysis among gay and bisexual men who have sex with men with and without mpox infection. Sexually Transmitted Infections. 99(8). 541–547. 3 indexed citations
7.
Carbó, Adrián Valls, Ana García Álvarez, Noemí Cabello, et al.. (2023). Differences in the inflammatory response among hospitalized patients with distinct variants of SARS-CoV-2. Frontiers in Immunology. 14. 1267991–1267991. 1 indexed citations
8.
Martínez-García, Laura, Eva Orviz, José María González‐Alba, et al.. (2023). Rapid expansion of lymphogranuloma venereum infections with fast diversification and spread of Chlamydia trachomatis L genovariants. Microbiology Spectrum. 12(1). e0285523–e0285523. 3 indexed citations
9.
Hernáez, Bruno, Ana Muñoz‐Gómez, África Sanchiz, et al.. (2022). Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study. The Lancet Microbe. 4(1). e21–e28. 51 indexed citations
10.
Martínez-García, Laura, José María González‐Alba, Teresa Puerta, et al.. (2022). Specific high-resolution scheme to improve understanding of the spatio-temporal dispersion of lymphogranuloma venereum epidemic. Frontiers in Microbiology. 13. 1056216–1056216. 2 indexed citations
11.
Martínez‐Sanz, Javier, Sergio Serrano‐Villar, Alfonso Muriel, et al.. (2022). Metabolic-Related Outcomes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study. Clinical Infectious Diseases. 76(3). e652–e660. 16 indexed citations
12.
Orviz, Eva, et al.. (2020). HIV screening and its possible involvement in patients with stroke. Enfermedades infecciosas y microbiologia clinica (English ed ). 38(7). 350–351. 2 indexed citations
13.
Orviz, Eva, et al.. (2020). Strategies for improving the antibiotic treatment prescription in the Emergency Department. Revista Española de Quimioterapia. 33(1). 85–86. 1 indexed citations
14.
Castillo, Juan González del, Darius Cameron Wilson, Inmaculada Mora-Jiménez, et al.. (2019). Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission. Critical Care. 23(1). 335–335. 22 indexed citations
15.
Méndez‐Bailón, Manuel, et al.. (2019). Ecografía pulmonar en la insuficiencia cardiaca. Revista Clínica Española. 220(4). 250–255. 2 indexed citations
16.
Méndez‐Bailón, Manuel, et al.. (2019). Lung ultrasound in heart failure. Revista Clínica Española (English Edition). 220(4). 250–255.
17.
Orviz, Eva, et al.. (2018). Salud Cardiovascular En Población Migrante Ecuatoriana En Madrid (España). ¿Debemos Preocuparnos?. Revista Ecuatoriana de Neurologia. 27(3). 16–19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026